HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.

Abstract
The mu opioid receptor, MOR, displays spontaneous agonist-independent (basal) G protein coupling in vitro. To determine whether basal MOR signaling contributes to narcotic dependence, antagonists were tested for intrinsic effects on basal MOR signaling in vitro and in vivo, before and after morphine pretreatment. Intrinsic effects of MOR ligands were tested by measuring GTPgammaS binding to cell membranes and cAMP levels in intact cells. beta-CNA, C-CAM, BNTX, and nalmefene were identified as inverse agonists (suppressing basal MOR signaling). Naloxone and naltrexone were neutral antagonists (not affecting basal signaling) in untreated cells, whereas inverse agonistic effects became apparent only after morphine pretreatment. In contrast, 6alpha- and 6beta-naltrexol and -naloxol, and 6beta-naltrexamine were neutral antagonists regardless of morphine pretreatment. In an acute and chronic mouse model of morphine-induced dependence, 6beta-naltrexol caused significantly reduced withdrawal jumping compared to naloxone and naltrexone, at doses effective in blocking morphine antinociception. This supports the hypothesis that naloxone-induced withdrawal symptoms result at least in part from suppression of basal signaling activity of MOR in morphine-dependent animals. Neutral antagonists have promise in treatment of narcotic addiction.
AuthorsD Wang, K M Raehal, E J Bilsky, W Sadée
JournalJournal of neurochemistry (J Neurochem) Vol. 77 Issue 6 Pg. 1590-600 (Jun 2001) ISSN: 0022-3042 [Print] England
PMID11413242 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Analgesics, Opioid
  • Benzylidene Compounds
  • Narcotic Antagonists
  • Receptors, Opioid, mu
  • Sulfur Radioisotopes
  • Tritium
  • 7-benzylidenenaltrexone
  • Naloxone
  • Guanosine 5'-O-(3-Thiotriphosphate)
  • 6 beta-hydroxynaltrexone
  • Naltrexone
  • chlornaltrexamine
  • Morphine
  • Cyclic AMP
  • Magnesium
  • nalmefene
Topics
  • Analgesics, Opioid (pharmacology)
  • Animals
  • Benzylidene Compounds (pharmacology)
  • Cell Line
  • Cell Membrane (metabolism)
  • Cyclic AMP (metabolism)
  • Dose-Response Relationship, Drug
  • Guanosine 5'-O-(3-Thiotriphosphate) (metabolism, pharmacology)
  • Humans
  • Kidney (cytology)
  • Magnesium (metabolism)
  • Male
  • Mice
  • Mice, Inbred ICR
  • Morphine (pharmacology)
  • Morphine Dependence (metabolism)
  • Naloxone (pharmacology)
  • Naltrexone (analogs & derivatives, pharmacology)
  • Narcotic Antagonists (pharmacology)
  • Nociceptors (drug effects)
  • Receptors, Opioid, mu (agonists, antagonists & inhibitors, metabolism)
  • Signal Transduction (drug effects, physiology)
  • Substance Withdrawal Syndrome (drug therapy)
  • Sulfur Radioisotopes
  • Transfection
  • Tritium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: